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ABSTRACT: The isolation of the oily fraction obtained from the CHCl3-soluble extract of 
the rhizomes of Kaempferia pulchra (Zingiberaceae) afforded five new isopimarane 
diterpenoids, kaempulchraols P−T (1−5), along with two known analogues. The structures 
were elucidated using spectroscopic techniques, including 2D NMR spectroscopy.  
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Kaempferia pulchra Ridl. [syn. Kaempferia elegans (Wall.) Baker], a member of the 
Zingiberaceae family, is known as “Shan-pan-oot” in Myanmar. The rhizomes have been 
reported to possess anti-inflammatory1 and antitumor activities2 and are popular for 
self-medication among patients with cancer and AIDS in Myanmar. In the ongoing research 
on the discovery of anticancer agents from Myanmar medicinal plants,3−8 the crude extracts 
were screened against a panel of five human cancer cell lines (A549, human lung cancer; 
HeLa, human cervix cancer; PANC-1 and PSN-1, human pancreatic cancer; and 
MDA-MB-231, human breast cancer) and TIG-3, a normal human primary fibroblast cell line. 
Because the CHCl3-soluble fraction of the rhizomes of K. pulchra exhibited reasonable 
antiproliferative activity against the tested cancer cell lines, we proceeded with the isolation 
of its secondary metabolites. In the two preceding papers, 15 new isopimarane-type 
diterpenoids were reported, i.e., kaempulchraols A−O, together with six known compounds 
[9α-hydroxyisopimara-8(14),15-dien-7-one,9 7β,9α-dihydroxypimara-8(14),15-diene,10 
(1S,5S,9S,10S,11R,13R)-1,11-dihydroxypimara-8(14),15-diene,11 
sandaracopimaradien-1α,2α-diol,1 (2R)-ent-2-hydroxyisopimara-8(14),15-diene,12 and 
(1R,2S,5S,9S,10S,11R,13R)-1,2,11-trihydroxypimara-8(14),15-diene]11 as well as their 
antiproliferative activities.7, 8 Further investigation of the remaining oily fractions obtained 
from the CHCl3-soluble extract led to the isolation of five new components, which were 
named kaempulchraols P−T (1−5) (Figure 1), along with the known 
7α-hydroxyisopimara-8(14),15-diene13 and ethyl 4-methoxy-trans-cinnamate.1 Herein, we 
describe the isolation and structural elucidation of the isolated compounds. 
Kaempulchraol P (1) was obtained as an amorphous solid, and its molecular formula was 
established as C20H32O from the HREIMS and 13C NMR data. The IR spectrum of 1 showed 
absorption bands at 3483 and 1635 cm−1 due to the presence of hydroxy and olefinic groups, 
respectively. The 1H NMR data (Table 1) exhibited signals corresponding to the presence of a 
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terminal vinyl group [δH 5.78, dd (J = 17.7, 10.2 Hz, H-15), 4.93, dd (J = 17.7, 1.5 Hz, 
H-16a), 4.91, dd (J = 10.2, 1.5 Hz, H-16b)]; three methines, including an oxygenated methine 
[δH 1.08, d (J = 1.4 Hz, H-5α), 4.33, br t (J = 4.2 Hz, H-6α), 1.74, br t (J = 7.6 Hz, H-9α)]; 
six methylenes; and four methyl groups [δH 1.09, s (H3-17), 1.24, s (H3-18), 1.00, s (H3-19), 
1.12, s (H3-20)]. The 13C NMR data (Table 2) revealed the presence of four olefinic carbons 
[δC 148.2 (C-15), 133.4 (C-8), 132.3 (C-14), 110.6 (C-16)]; three methine carbons, including 
an oxymethine carbon [δC 68.4 (C-6), 56.8 (C-5), 50.4 (C-9)]; three quaternary carbons [δC 
39.4 (C-10), 37.6 (C-13), 34.22 (C-4)]; six methylenes [δC 45.8 (C-7), 43.9 (C-3), 42.4 (C-1), 
34.25 (C-12), 19.1 (C-2), 18.4 (C-11)]; and four methyl carbons [δC 33.8 (C-19), 26.6 (C-17), 
23.9 (C-18), 18.8 (C-20)]. These data suggested that 1 is a monohydroxy derivative of a 
Δ8(14),15-isopimaradiene. The key HMBC correlations from an oxygenated methine (δH 4.33, 
H-6α) to C-5/C-8/C-10 located the hydroxy group at C-6 (Figure 2). According to the 
NOESY correlations between H-6α and H-5α/H3-19, and biosynthetic considerations, C-6 
hydroxy group was assigned as β orientation and the structure was elucidated as 
6β-hydroxyisopimara-8(14),15-diene.  
Kaempulchraol Q (2) was isolated as an amorphous solid and exhibited a deprotonated 
molecular ion at m/z 345.2431 in HRCIMS, which, in conjunction with the 13C NMR data 
suggested a molecular formula of C22H34O3. The IR spectrum exhibited absorption bands at 
3508, 1714, and 1632 cm−1 due to the presence of hydroxy, ester, and olefinic groups. The 1H 
and 13C NMR spectroscopic data (Tables 1 and 2) of 2 were similar to those of 1 except for 
the presence of an acetoxy group [δH 2.07, s; δC 21.2 (MeOCO-1), δC 170.2 (MeOCO-1)] and 
two oxygenated methines [δH 4.78, br t (J = 2.1 Hz, H-1β), 4.38, br s (H-6α)], characterizing 
2 as a Δ8(14),15-isopimaradiene carrying a hydroxy and an acetoxy substituents. On the basis of 
the HMBC correlations from MeOCO-1 to MeOCO-1/C-1, from H3-20 (δH 1.16, s)/H-5α (δH 
1.49, d, J = 1.7 Hz)/H-9α (δH 2.18, br t, J = 5.3 Hz) to C-1, from H-5α/H2-7 to C-6 (δC 68.3), 
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and from H-6α to C-5 (δC 51.0)/C-8 (δC 133.2)/C-10 (δC 42.0) (Figure 2), the acetoxy and 
hydroxy groups were located at C-1 and C-6, respectively. The NOESY correlations of H-1β 
and H3-20 and of H-6α and H-5α/H3-19 suggested α and β orientations of the C-1 acetoxy 
and C-6 hydroxy groups, respectively. Hence, the structure of kaempulchraol Q (2) was 
elucidated as 1α-acetoxy-6β-hydroxyisopimara-8(14),15-diene. 
Kaempulchraol R (3) was isolated as an amorphous solid, and its molecular formula, 
C22H34O3, was determined from the 13C NMR data and protonated molecular ion at m/z 
347.2586. The 1H and 13C NMR spectroscopic data (Tables 1 and 2) of 3 were similar to 
those of 2. Important differences included the absence of the resonance of one oxygenated 
methine proton in the 1H NMR spectrum of 3, whereas the presence of two oxygenated 
carbons in the 13C NMR spectrum of 3 suggested that one of the oxygen bearing groups is 
attached to a tertiary carbon. The key HMBC correlations (Figure 2) between a hydroxy 
proton (δH 2.63, s) and C-9 (δC 74.8)/C-10 (δC 41.6)/C-11 (δC 25.6) and between H-5α (δH 
1.92, dd, J = 13.6, 2.8)/H-7β (δH 5.42, t, J = 3.3 Hz)/H2-11 (δH 1.58, 1.78, both m)/H-14 (δH 
5.78, s) and C-9 indicated that the hydroxy group was located at C-9. Further HMBC 
correlations of an oxygenated methine (δH 5.42, t, J = 3.3 Hz, H-7β) and C-5 (δC 39.5)/C-8 
(δC 133.3)/C-9/C-14 (δC 141.3) and of MeOCO-7 (δH 2.04, s) and MeOCO-7 (δC 169.2)/C-7 
(δC 77.1) located the acetoxy group at C-7. The α orientations of the C-9 hydroxy and C-7 
acetoxy groups were confirmed by the NOESY correlations between HO-9 and H-5α and 
between H-7β and H-6β (δH 1.56, m)/H3-17 (δH 1.03, s). Thus, the structure of kaempulchraol 
R (3) was assigned as 7α-acetoxy-9α-hydroxyisopimara-8(14),15-diene. 
Kaempulchraol S (4) was obtained as an amorphous solid, and its molecular formula was 
determined as C20H30O2 by HREIMS and 13C NMR data. The 1H and 13C NMR spectroscopic 
data of 4 (Tables 1 and 2) were similar to those of kaempulchraol G.7 The presence of an 
oxygenated methine proton (δH 4.28, s) and a carbonyl carbon (δC 201.6) suggested 4 to be a 
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Δ8(9),15-isopimaradiene with a hydroxy and carbonyl group. However, the locations of these 
hydroxy and carbonyl groups in 4 were different from those of kaempulchraol G. The HMBC 
correlations (Figure 2) from H-5α (δH 1.66, dd, J = 14.2, 3.5 Hz)/H-14β (δH 4.28, s) to the 
carbonyl carbon and from H-14β to C-7/C-8 (δC 131.6)/C-9 (δC 169.6)/C-12 (δC 28.3)/C-13 
(δC 38.4)/C-15 (δC 143.5)/C-17 (δC 23.4) located the carbonyl group at C-7 and the hydroxy 
group at C-14. The NOESY correlations between H-14β and H3-17 (δH 1.12, s) established 
the α orientation of the C-14 hydroxy group. Accordingly, kaempulchraol S (4) was 
characterized as 7-oxo-14α-hydroxyisopimara-8(9),15-diene.       
Kaempulchraol T (5) was obtained as an amorphous solid. The HRCIMS spectrum of 5 
exhibited a protonated molecular ion at m/z 347.2601, which, in conjunction with the 13C 
NMR data, indicated a molecular formula of C22H34O3. The 1H and 13C NMR spectroscopic 
data together with the COSY and HMQC correlations (Figure 2) resembled those of 2. The 
differences were the positions of the hydroxy and acetoxy groups, which were located at C-6 
and C-7 based on the HMBC correlations from H-6α (δH 4.17, m) and H-7β (δH 5.03, d, J = 
2.9 Hz) to C-5 (δC 51.8)/C-8 (δC 132.0) and from MeOCO-7 (δH 2.04, s) to MeOCO-7 (δC 
169.8)/C-7 (δC 79.0) (Figure 2). The NOESY correlations between H-6α and H-5α (δH 1.36, 
d, J = 1.9 Hz)/H3-19 (δH 0.96, s) and between H-7β and H3-17 (δH 1.09, s) established the 
orientations of the C-6 hydroxy and the C-7 acetoxy groups as β and α, respectively. 
Therefore, the structure of kaempulchraol T (5) was defined as 
6β-hydroxy-7α-acetoxyisopimara-8(14),15-diene. 
The two known compounds were identified as 7α-hydroxyisopimara-8(14),15-diene13 and 
ethyl 4-methoxy-trans-cinnamate1 based on the observed and reported NMR data.  
 
EXPERIMENTAL SECTION 
General Experimental Procedures. Optical rotations were recorded on a JASCO P2100 
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polarimeter. Infrared spectra were recorded using KBr pellets on a Jasco FT/IR-460 Plus 
spectrometer. NMR spectra were recorded at 600 MHz (1H NMR) and 150 MHz (13C NMR) 
on a Varian UNITY 600 spectrometer. Chemical shift values were expressed in δ (ppm) 
downfield from TMS as an internal standard. The mass spectra, HRMS data, were recorded 
on a JEOL MStation JMS-700 spectrometer. Open-column chromatography was performed 
with normal-phase silica gel (silica gel 60N, spherical, neutral, 40−50 µm, Kanto Chemical 
Co., Inc., Japan) and Cosmosil 75C18-OPN (Nacalai Tesque Inc., Kyoto, Japan). MPLC was 
performed with a Bü chi Sepacore system (Büchi Labortechnik AG, Flawil, Switzerland). 
TLC was conducted on precoated silica gel 60F254 and RP-18 F254 plates (Merck; 0.25 or 0.50 
mm thickness).  
Plant Material. Rhizomes of K. pulchra were collected from Pindaya Township, Shan 
State, Myanmar, in September 2013 and were identified by the authorized botanist of the 
Department of Botany, University of Yangon. A voucher specimen (TMPW 28301) was 
deposited at the Museum for Materia Medica, Analytical Research Center for 
Ethnomedicines, Institute of Natural Medicine, University of Toyama, Japan.  
Extraction and Isolation. The rhizomes of K. pulchra (500 g) were extracted with CHCl3 
under sonication (1 L, 90 min, ×3) at 35 °C, and the solvent was evaporated under reduced 
pressure to yield 30 g of extract.  
The chloroform extract (30 g) was chromatographed on silica gel with an 
EtOAc−n-hexane solvent system to provide seven fractions. The isolation and purification of 
subfraction 2-2 to fraction 6 by various chromatographic techniques afforded kaempulchraols 
A−O and six known compounds.7, 8 
Subfraction 2-1 (645 mg) was rechromatographed on silica gel with n-hexane−EtOAc 
(4:1) to afford three subfractions [2-1-1: 200 mg; 2-2-2: 146 mg; 2-1-3: 200 mg]. The 
purification of subfraction 2-1-1 (200 mg) by normal-phase preparative TLC with 
C6H6−CHCl3 (1:1) afforded kaempulchraol P (1, 80 mg), 
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7α-hydroxyisopimara-8(14),15-diene (30 mg),13 and ethyl 4-methoxy-trans-cinnamate1 (50 
mg). Subfraction 2-1-2 (146 mg) was purified by normal-phase preparative TLC with 
n-hexane−EtOAc (3:1) followed by reverse-phase preparative TLC with MeOH−MeCN−H2O 
(7:2:1) to give kaempulchraols Q (2, 38 mg) and R (3, 68 mg). The purification of subfraction 
2-1-3 (200 mg) by normal-phase preparative TLC with n-hexane−EtOAc (3:1) followed by 
reverse-phase preparative TLC with MeOH−MeCN−acetone−H2O (2:2:2:1) afforded 
kaempulchraols S (4, 65 mg) and T (5, 5 mg).  
Kaempulchraol P (1): amorphous solid; [α]25D −20 (c 0.1, MeOH); IR (KBr) νmax 3483, 
2920, 1635, 1542, 1458, 1036, 997 cm−1; 1H and 13C NMR data, see Tables 1 and 2; EIMS 
m/z 288 [M]+ (38); HREIMS m/z 288.2457 [M]+ (calculated for C20H32O, 288.2453).  
Kaempulchraol Q (2): amorphous solid; [α]25D −39 (c 0.1, MeOH); IR (KBr) νmax 3508, 
2954, 1714, 1632, 1262, 1035, 989 cm−1; 1H and 13C NMR data, see Tables 1 and 2; CIMS 
m/z 345 [M−H]+ (10); HRCIMS m/z 345.2431 [M−H]+ (calculated for C22H33O3, 345.2430).  
Kaempulchraol R (3): amorphous solid; [α]25D −36 (c 0.1, MeOH); IR (KBr) νmax 3596, 
2951, 1743, 1634, 1372, 1227, 1014, 991 cm−1; 1H and 13C NMR data, see Tables 1 and 2; 
CIMS m/z 346 [M]+ (6); HRCIMS m/z 347.2586 [M+H]+ (calculated for C22H35O3, 
347.2586).  
Kaempulchraol S (4): amorphous solid; [α]25D +30 (c 0.1, MeOH); IR (KBr) νmax 3461, 
2928, 1652, 1617, 1375, 1253, 1046, 1005 cm−1; 1H and 13C NMR data, see Tables 1 and 2; 
EIMS m/z 302 [M]+ (15); HREIMS m/z 302.2242 [M]+ (calculated for C20H30O2, 302.2246).  
Kaempulchraol T (5): amorphous solid; [α]25D −32 (c 0.1, MeOH); IR (KBr) νmax 3503, 
2923, 1718, 1636, 1367, 1236, 1041, 953 cm−1; 1H and 13C NMR data, see Tables 1 and 2; 
CIMS m/z 346 [M]+ (18); HRCIMS m/z 347.2601 [M+H]+ (calculated for C22H35O3, 
347.2586).  
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Table 1. 1H NMR Spectroscopic Data (600 MHz, CDCl3) of Kaempulchraols P−T (1−5), (δ  in ppm and J 
values in (Hz) in parentheses) 
position 1 2 3 4 5 
1α 1.73, m  1.71, m 1.19, m 1.10, m 
1β 1.05, m 4.78, br t (2.1) 1.39, m 1.83, m 1.74, m 
2α 1.46a, m 1.70, ddd  
(14.6, 6.8, 3.7) 
1.50a, m 1.56, m 1.48, m 
2β 1.46a, m 1.84, tdd  
(14.6, 3.7, 2.1) 
1.50a, m 1.67, m 1.61, m 
3α 1.20, m 1.56, m 1.41, m 1.20, m 1.26, m 
3β 1.41, m 1.15, m 1.25, m 1.47a, m 1.41, m 
5α 1.08, d (1.4) 1.49, d (1.7) 1.92, dd  
(13.6, 2.8) 
1.66, dd  
(14.2, 3.5) 
1.36, d (1.9) 
6α 4.33, br t (4.2) 4.38, br s 1.81, dt  
(12.8, 2.8) 
2.52, dd  
(17.9, 3.5) 
4.17, m 
6β   1.56, m 2.39, dd  
(17.9, 14.2) 
 
7α 2.35, m 2.35, m    
7β 2.27, dd (14.4, 2.7) 2.26, dd (14.4, 2.7) 5.42, t (3.3)  5.03, d (2.9) 
9α 1.74, br t (7.6) 2.18, br t (5.3)   2.00, t (5.7) 
11α 1.59, m 1.40, m 1.78, m 2.23a, m 1.61a, m 
11β 1.62, m 1.54, m 1.58, m 2.23a, m 1.61a, m 
12α 1.38, m 1.37, m 1.75, m 1.70, m 1.39, m 
12β 1.51, m 1.46, m 1.42, m 1.47a, m 1.51, m 
14 5.39, br s 5.44, br t (1.72) 5.78, s  5.80, d (1.8) 
14α      
14β    4.28, s  
15 5.78, dd 
(17.7, 10.2) 
5.76, dd 
(17.2, 10.7) 
5.81, dd 
(17.4, 10.6) 
5.67, dd 
(17.7, 11.0) 
5.74, dd 
(17.4, 10.5) 
16a 4.93, dd 
(17.7, 1.5) 
4.90, dd 
(17.2, 1.5) 
4.99, dd 
(17.5, 1.1) 
4.94, dd 
(17.7, 1.1) 
4.89, dd 
(17.4, 1.4) 
16b 4.91, dd 
(10.2, 1.5) 
4.92, dd 
(10.7, 1.5) 
4.95, dd 
(10.6, 1.1) 
4.98, dd 
(11.0, 1.1) 
4.93, dd 
(10.5, 1.4) 
17 1.09, s 1.08, s 1.03, s 1.12, s 1.09, s 
18 1.24, s 1.27, s 0.87, m 0.93, s 1.24, s 
19 1.00, s 1.04, s 0.88, m 0.89, s 0.96, s 
20 1.12, s 1.16, s 0.89, m 1.13, s 1.12, s 
HO-7      
HO-9   2.63, s   
MeOCO-1  2.07, s    
MeOCO-7   2.04, s  2.04, s 
aOverlapping resonances within the same column. 
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Table 2. 13C NMR Spectroscopic Data (150 MHz, CDCl3) of Kaempulchraols P−T (1−5), (δ  in ppm) 
 
 position 1 2 3 4 5 
1 42.4 76.0 31.6 35.2 42.0 
2 19.1 22.9 18.5 18.4 19.1 
3 43.9 36.5 41.4 41.0 43.9 
4 34.22 33.8 32.7 33.1 33.8 
5 56.8 51.0 39.5 49.9 51.8 
6 68.4 68.3 27.5 35.5 69.9 
7 45.8 45.6 77.1 201.6 79.0 
8 133.4 133.2 133.3 131.6 132.0 
9 50.4 42.7 74.8 169.6 46.0 
10 39.4 42.0 41.6 39.8 39.1 
11 18.4 17.9 25.6 23.2 18.0 
12 34.25 33.9 30.9 28.3 34.0 
13 37.6 37.6 38.1 38.4 37.8 
14 132.3 133.0 141.3 68.1 139.4 
15 148.2 148.0 147.3 143.5 147.2 
16 110.6 110.7 111.1 112.6 111.6 
17 26.6 26.7 23.3 23.4 26.5 
18 23.9 24.1 21.8 21.3 24.4 
19 33.8 33.6 33.4 32.3 33.6 
20 18.8 18.7 17.9 17.9 18.5 
MeOCO-1  21.2    
MeOCO-1  170.2    
MeOCO-7   21.7  21.4 
MeOCO-7   169.2  169.8 
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Figure 1. Structures of Kaempulchraols P−T (1−5). 
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Figure 2. COSY (bold lines) and key HMBC (1H→13C) (arrows) correlations in compounds 1−5.  
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